Pfizer's third-quarter results grow strongly
This article was originally published in Clinica
Pfizer revenues and net income both grew 26% in the third quarter. Sales rose to $2,624 million and profits to $425 million. In the first nine months turnover was $7,509 million, also 26% up compared with the previous year, and net income $1,162 million, up 20%.